ASO Author Reflections: Resected Intraductal Papillary Mucinous Neoplasm-Derived Pancreatic Cancer: Early Recurrence and Patient-Tailored Management.
作者信息
Habib Joseph R, Rompen Ingmar F, Hidalgo Salinas Camila, Groot Vincent P, Javed Ammar A, Daamen Lois A
机构信息
Department of Surgery, New York University Langone Health, New York, NY, USA.
Department of Surgery, Regional Academic Cancer Center Utrecht, UMC Utrecht Cancer Center, St. Antonius Hospital Nieuwegein, Utrecht, The Netherlands.
出版信息
Ann Surg Oncol. 2025 Apr;32(4):2868-2869. doi: 10.1245/s10434-024-16810-8. Epub 2025 Jan 24.
Abstract
摘要
相似文献
1
ASO Author Reflections: Resected Intraductal Papillary Mucinous Neoplasm-Derived Pancreatic Cancer: Early Recurrence and Patient-Tailored Management.美国外科医师学会作者反思：切除的导管内乳头状黏液性肿瘤衍生的胰腺癌：早期复发与个体化患者管理
Ann Surg Oncol. 2025 Apr;32(4):2868-2869. doi: 10.1245/s10434-024-16810-8. Epub 2025 Jan 24.
2
ASO Author Reflections: Intraductal Papillary Mucinous Neoplasm-Derived Pancreatic Cancer: A Need to Evaluate for Specific Staging Systems.ASO作者反思：导管内乳头状黏液性肿瘤衍生的胰腺癌：需要评估特定的分期系统。
Ann Surg Oncol. 2024 Dec;31(13):8758-8759. doi: 10.1245/s10434-024-16131-w. Epub 2024 Sep 10.
3
Clinical significance of frozen section analysis during resection of intraductal papillary mucinous neoplasm: should a positive pancreatic margin for adenoma or borderline lesion be resected additionally?导管内乳头状黏液性肿瘤切除术中冰冻切片分析的临床意义：腺瘤或交界性病变的胰腺切缘阳性时是否应进一步切除？
J Am Coll Surg. 2009 Nov;209(5):614-21. doi: 10.1016/j.jamcollsurg.2009.07.023. Epub 2009 Sep 19.
4
Study of recurrence after surgical resection of intraductal papillary mucinous neoplasm of the pancreas.胰腺导管内乳头状黏液性肿瘤手术切除后复发的研究。
Gastroenterology. 2002 Nov;123(5):1500-7. doi: 10.1053/gast.2002.36552.
5
Long-term surveillance is necessary after operative resection for intraductal papillary mucinous neoplasm of the pancreas.胰腺导管内乳头状黏液性肿瘤手术切除后需要进行长期监测。
Surgery. 2016 Aug;160(2):306-17. doi: 10.1016/j.surg.2016.04.007. Epub 2016 May 25.
6
Clinicopathologic characteristics of patients with resected multifocal intraductal papillary mucinous neoplasm of the pancreas.切除胰腺多灶性导管内乳头状黏液性肿瘤患者的临床病理特征。
Surgery. 2012 Sep;152(3 Suppl 1):S74-80. doi: 10.1016/j.surg.2012.05.025. Epub 2012 Jul 6.
7
Defining and Predicting Early Recurrence for Optimal Treatment Strategies for Intraductal Papillary Mucinous Neoplasm-Derived Pancreatic Cancer: An International Multicenter Study.导管内乳头状黏液性肿瘤衍生胰腺癌的最佳治疗策略：早期复发的定义与预测——一项国际多中心研究
Ann Surg Oncol. 2025 Mar;32(3):1879-1886. doi: 10.1245/s10434-024-16649-z. Epub 2024 Dec 12.
8
Long-term (10-year) outcomes and prognostic factors in resected intraductal papillary mucinous neoplasm tumors in Finland: A nationwide retrospective study.芬兰切除性管内乳头状黏液性肿瘤的长期（10 年）结果和预后因素：一项全国性回顾性研究。
Surgery. 2023 Jul;174(1):75-82. doi: 10.1016/j.surg.2023.02.006. Epub 2023 Apr 15.
9
ASO Author Reflections: Response to Chemotherapy Differs between Precursor Epithelial Subtypes of Pancreatic Adenocarcinoma Arising from Intraductal Papillary Mucinous Neoplasms and may Warrant Tailored Treatment to Improve Outcomes.ASO作者反思：导管内乳头状黏液性肿瘤引发的胰腺导管腺癌前驱上皮亚型对化疗的反应不同，可能需要量身定制治疗方案以改善预后。
Ann Surg Oncol. 2024 Oct;31(10):7070-7071. doi: 10.1245/s10434-024-15784-x. Epub 2024 Jul 6.
10
ASO Author Reflections: Surgery for Intraductal Papillary Mucinous Neoplasm: Predicting Risk for Better Patient Selection.《美国外科医师学会杂志》作者反思：导管内乳头状黏液性肿瘤的手术治疗——预测风险以优化患者选择
Ann Surg Oncol. 2022 May;29(5):3215-3216. doi: 10.1245/s10434-022-11352-3. Epub 2022 Feb 14.
本文引用的文献
1
Defining and Predicting Early Recurrence for Optimal Treatment Strategies for Intraductal Papillary Mucinous Neoplasm-Derived Pancreatic Cancer: An International Multicenter Study.导管内乳头状黏液性肿瘤衍生胰腺癌的最佳治疗策略：早期复发的定义与预测——一项国际多中心研究
Ann Surg Oncol. 2025 Mar;32(3):1879-1886. doi: 10.1245/s10434-024-16649-z. Epub 2024 Dec 12.
2
Impact of Adjuvant Chemotherapy on Resected Intraductal Papillary Mucinous Neoplasm-Derived Pancreatic Cancer: Results From an International Multicenter Study.辅助化疗对切除的导管内乳头状黏液性肿瘤衍生胰腺癌的影响：一项国际多中心研究的结果
J Clin Oncol. 2024 Dec 20;42(36):4317-4326. doi: 10.1200/JCO.23.02313. Epub 2024 Sep 10.
3
Outcomes in intraductal papillary mucinous neoplasm-derived pancreatic cancer differ from PanIN-derived pancreatic cancer.导管内乳头状黏液性肿瘤衍生的胰腺癌的预后与胰腺上皮内瘤变衍生的胰腺癌不同。
J Gastroenterol Hepatol. 2024 Nov;39(11):2360-2366. doi: 10.1111/jgh.16686. Epub 2024 Jul 31.
4
Risk of Recurrence After Surgical Resection for Adenocarcinoma Arising From Intraductal Papillary Mucinous Neoplasia (IPMN) With Patterns of Distribution and Treatment: An International, Multicenter, Observational Study (ADENO-IPMN Study).导管内乳头状黏液性肿瘤（IPMN）相关腺癌手术切除后的复发风险、分布模式及治疗：一项国际多中心观察性研究（ADENO - IPMN研究）
Ann Surg. 2024 Jul 1;280(1):126-135. doi: 10.1097/SLA.0000000000006144. Epub 2023 Oct 24.
5
Global genomic analysis of intraductal papillary mucinous neoplasms of the pancreas reveals significant molecular differences compared to ductal adenocarcinoma.胰腺导管内乳头状黏液性肿瘤的全基因组分析显示，与导管腺癌相比，存在显著的分子差异。
Ann Surg. 2009 Mar;249(3):440-7. doi: 10.1097/SLA.0b013e31819a6e16.
Zotero 插件